Literature DB >> 22352842

Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress.

Jianguo Lin1, Youcai Tang, Qiaohua Kang, Yunfeng Feng, Anping Chen.   

Abstract

BACKGROUND AND
PURPOSE: Diabetes is characterized by hyperglycaemia, which facilitates the formation of advanced glycation end-products (AGEs). Type 2 diabetes mellitus is commonly accompanied by non-alcoholic steatohepatitis, which could lead to hepatic fibrosis. Receptor for AGEs (RAGE) mediates effects of AGEs and is associated with increased oxidative stress, cell growth and inflammation. The phytochemical curcumin inhibits the activation of hepatic stellate cells (HSCs), the major effectors during hepatic fibrogenesis. The aim of this study was to explore the underlying mechanisms of curcumin in the elimination of the stimulating effects of AGEs on the activation of HSCs. We hypothesize that curcumin eliminates the effects of AGEs by suppressing gene expression of RAGE. EXPERIMENTAL APPROACH: Gene promoter activities were evaluated by transient transfection assays. The expression of rage was silenced by short hairpin RNA. Gene expression was analysed by real-time PCR and Western blots. Oxidative stress was evaluated. KEY
RESULTS: AGEs induced rage expression in cultured HSCs, which played a critical role in the AGEs-induced activation of HSCs. Curcumin at 20 µM eliminated the AGE effects, which required the activation of PPARγ. In addition, curcumin attenuated AGEs-induced oxidative stress in HSCs by elevating the activity of glutamate-cysteine ligase and by stimulating de novo synthesis of glutathione, leading to the suppression of gene expression of RAGE. CONCLUSION AND IMPLICATIONS: Curcumin suppressed gene expression of RAGE by elevating the activity of PPARγ and attenuating oxidative stress, leading to the elimination of the AGE effects on the activation of HSCs. LINKED ARTICLE: This article is commented on by Stefanska, pp. 2209-2211 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476-5381.2012.01959.x.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22352842      PMCID: PMC3448888          DOI: 10.1111/j.1476-5381.2012.01910.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  86 in total

1.  The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro.

Authors:  Yajun Zhou; Shizhong Zheng; Jianguo Lin; Qian-Jin Zhang; Anping Chen
Journal:  Lab Invest       Date:  2007-03-19       Impact factor: 5.662

2.  Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.

Authors:  Shizhong Zheng; Anping Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-09-07       Impact factor: 4.052

Review 3.  International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

Authors:  Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell A Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

4.  Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.

Authors:  Yumei Fu; Shizhong Zheng; Jianguo Lin; Jan Ryerse; Anping Chen
Journal:  Mol Pharmacol       Date:  2007-11-15       Impact factor: 4.436

5.  Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling.

Authors:  A Chen; S Zheng
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

6.  The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes.

Authors:  H Scharnagl; T Stojakovic; K Winkler; S Rosinger; W März; B O Boehm
Journal:  Exp Clin Endocrinol Diabetes       Date:  2007-06       Impact factor: 2.949

Review 7.  Vitamin E in chronic liver diseases and liver fibrosis.

Authors:  Antonio Di Sario; Cinzia Candelaresi; Alessia Omenetti; Antonio Benedetti
Journal:  Vitam Horm       Date:  2007       Impact factor: 3.421

Review 8.  Present and future therapeutic strategies in non-alcoholic fatty liver disease.

Authors:  Giuseppe Calamita; Piero Portincasa
Journal:  Expert Opin Ther Targets       Date:  2007-09       Impact factor: 6.902

9.  De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation.

Authors:  Shizhong Zheng; Fu Yumei; Anping Chen
Journal:  Free Radic Biol Med       Date:  2007-04-29       Impact factor: 7.376

10.  Unchanged serum levels of advanced glycation endproducts in patients with liver disease.

Authors:  Moritz Butscheid; Christian Schäfer; Stefanie Brenner; Dominik Alscher; Thomas Mürdter; Toshimitsu Niwa; Matthias Frischmann; Monika Pischetsrieder; Ulrich Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-15       Impact factor: 3.195

View more
  34 in total

1.  Perilipin 5 and liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells.

Authors:  Jianguo Lin; Shizhong Zheng; Alan D Attie; Mark P Keller; David A Bernlohr; William S Blaner; Elizabeth P Newberry; Nicholas O Davidson; Anping Chen
Journal:  J Lipid Res       Date:  2018-01-09       Impact factor: 5.922

Review 2.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

3.  Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response.

Authors:  Xiao-Qun Han; Zuo-Jiong Gong; San-Qing Xu; Xun Li; Li-Kun Wang; Shi-Min Wu; Jian-Hong Wu; Hua-Fen Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

Review 4.  Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.

Authors:  Raquel López-Díez; Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Biochim Biophys Acta       Date:  2016-05-08

Review 5.  AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.

Authors:  Kailash Prasad; Manish Mishra
Journal:  Int J Angiol       Date:  2017-12-28

Review 6.  Potential effects of curcumin on peroxisome proliferator-activated receptor-γ in vitro and in vivo.

Authors:  Mohsen Mazidi; Ehsan Karimi; Mohsen Meydani; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  World J Methodol       Date:  2016-03-26

7.  Small interfering RNA targeting receptor for advanced glycation end products suppresses the generation of proinflammatory cytokines.

Authors:  Xiao-Wei Wang; Wei-Dong Li; Jin-Rong Xia; Zhan Li; Xiao-Gang Cai
Journal:  Exp Ther Med       Date:  2015-06-11       Impact factor: 2.447

Review 8.  RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review.

Authors:  Gowri Palanissami; Solomon F D Paul
Journal:  Horm Cancer       Date:  2018-07-09       Impact factor: 3.869

Review 9.  AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2019-05-11       Impact factor: 3.396

10.  Perilipin 5 restores the formation of lipid droplets in activated hepatic stellate cells and inhibits their activation.

Authors:  Jianguo Lin; Anping Chen
Journal:  Lab Invest       Date:  2016-05-02       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.